Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.99NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.99NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.162ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.162SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.162SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.162EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.162NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.162NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Y.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
Y.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Y.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Y.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
Y.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Y.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Y.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Y.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.86ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.86ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.86SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.86SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.86EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.86NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.86NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.154ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.154ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.154SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.154SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.154EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.154EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.154NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.154NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.4.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.4.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.4.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.4.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
A.2.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
A.2.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
A.2.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
A.2.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
A.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.41ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used